m-Health Solutions and Hamilton Health Sciences Partner to Develop Ground-breaking m-CARDS Technology in the Fight Against Heart Disease
Burlington, ON, March 23, 2018 – Partnering to save more patients undergoing transcatheter aortic valve replacement (TAVR), m-Health Solutions and Hamilton Health Sciences are grant recipients from the Government of Ontario’s Health Technologies Fund (HTF) that will push research and results for Canadians battling heart disease.
Approximately 1000 patients undergo TAVR surgery in Ontario yearly, and that number is expected to increase to ~80% of all valve replacement surgery within the next 5 years. The average recovery time is 7 days which requires the use of an expensive telemetry bed in hospital.
Combined with the ongoing rise in the geriatric population across Canada, health care costs could be greatly reduced through the new mobile Cardiac Arrhythmia Diagnostics Service (m-CARDSTM). More importantly, with patients able to recover and be monitored at home, the quality of the recovery improves and the risk for hospital acquired infection is greatly reduced.
Other partners involved in this innovative project include Institute of Clinical Evaluation Sciences (ICES), Sunnybrook Health Sciences, CorHealth Ontario, Centre for Effective Practice, and Waterloo Wellington LHIN.
“We are incredibly excited to partner with such innovative organizations such as Hamilton Health Sciences and Sunnybrook Hospital”, says Sandy Schwenger, CEO of m-Health Solutions. “Partnerships like these, with the involvement of the Government of Ontario, allow us to bring technology like the mobile Cardiac Arrhythmia Diagnostics Service forward faster and save the lives of more Canadians.”
Physicians with Hamilton Health Sciences have identified how m-Health Solutions could fill a post-operative gap in care. Ted Scott, Interim Vice President Research & Chief Innovation Officer at Hamilton Health Sciences says, “Remote patient monitoring using innovative technologies like m-CARDS is a vitally important step for hospitals transforming care models to be future ready.”
This technology is one of 12 innovative projects to be supported through the second round of the HTF. HTF is a program of the Government of Ontario’s Office of the Chief Health Innovation Strategist (OCHIS), administered by the Ontario Centres of Excellence (OCE).
“The Health Technologies Fund has already made significant impact across the province. These projects are improving patient outcomes and system workflows while scaling Ontario-based health technology companies,” says William Charnetski, Chief Health Innovation Strategist for Ontario. “It is exciting to see the second cohort of recipients address challenges to the health system and grow our economy.”
About the Office of the Chief Health Innovation Strategist:
The Office of the Chief Health Innovation Strategist (OCHIS) was created in September of 2015 to fulfill the recommendations made by the Ontario Health Innovation Council (OHIC) established by the Ontario government in 2013. The council submitted is report, The Catalyst, in December 2014.
OCHIS is a catalyst to help accelerate health technology commercialization efforts in Ontario. The purpose of the office is to drive collaboration across the health care system to accelerate the adoption and diffusion of new innovative health technologies and processes to:
- Improve patient outcomes (in accordance with the Ministry of Health and Long-Term Care’s Patients First: Action Plan for Health Care)
- Optimize impact of investment in health innovation
- Scale health innovation companies
To be world-leading, Ontario’s health technology companies need to generate significant export activity. OCHIS supports efforts to champion them in global markets.